Update on HIV-1 infection in children

Paediatrics and Child Health

Volumn 18, Issue 11, 2008, Pages 496-501

  Chakraborty, Rana ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

adolescence; children; disease progression; HAART; HIV; mother to child transmission

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; AZELASTINE; EFAVIRENZ; EMTRICITABINE; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR; ZIDOVUDINE;

AFRICA; BREAST FEEDING; BREAST MILK; CLINICAL FEATURE; COMPARATIVE STUDY; DISEASE COURSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANCY; INFANT MORTALITY; INTERVENTION STUDY; MONOTHERAPY; MORBIDITY; MOTHER; OBSTETRICS; PANDEMIC; PEDIATRICS; PERINATAL PERIOD; PRACTICE GUIDELINE; PREGNANT WOMAN; PROPHYLAXIS; REVIEW; SCREENING; SURVIVAL; SURVIVAL TIME; UNITED KINGDOM; VIRUS CLASSIFICATION; VIRUS TRANSMISSION;

EID: 53649104660     PISSN: 17517222     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.paed.2008.07.010     Document Type: Review

References (11)

1. Uniting the World Against AIDS website. Available at:. http://www.unaids.org (accessed 22.07.08)
2. Nielsen K., Boyer P., Dillon M., et al. Presence of human immunodeficiency virus (HIV) type 1 and HIV-1-specific antibodies in cervicovaginal secretions of infected mothers and in the gastric aspirates of their infants. J Infect Dis 173 (1996) 1001-1004
3. Nduati R., John G., Mbori-Ngacha D., et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 283 (2000) 1167-1174
4. Semba R.D., Kumwenda N., Hoover D.R., et al. Human immunodeficiency virus load in breast milk, mastitis, and mother-to- child transmission of human immunodeficiency virus type 1. J Infect Dis 180 (1999) 93-98
5. de Ruiter A., Mercey D., Anderson J., et al. British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008. HIV Med 9 (2008) 452-502
6. Shearer W.T., Quinn T.C., LaRussa P., et al. Viral load and disease progression in infants infected with HIV-1. women and infants transmission study group. N Engl J Med 336 (1997) 1337-1342
7. Children's HIV Association. Treating opportunistic infections in HIV-infected children. (extended). Available at: (September 2006). http://www.chiva.org.uk/protocols/ois-long.html (accessed 22.07.08)
8. Gibb D.M., Duong T., Tookey P.A., et al., National Study of HIV in Pregnancy and Childhood Collaborative HIV Paediatric Study. Decline in mortality, AIDS and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland. BMJ 327 (2003) 1019
9. Sharland M., Blanche S., Castelli G., Ramos J., and Gibb D.M. PENTA Steering Comittee. PENTA guidelines for the use of antiretroviral therapy, 2004. HIV Med 5 Suppl 2 (2004) 61-86
10. Dunn D., and HIV Paediatric Prognostic Markers Collaborative Study Group. Short term risk of disease progression in HIV-1 infected children receiving no antiretroviral therapy or zidovudine monotherapy; a meta-analysis. Lancet 362 (2003) 1605-1611
11. HIV Paediatric Prognostic Markers Collaborative Study. Predictive value of absolute CD4 cell count for disease progression in untreated HIV-1-infected children. AIDS 20 (2006) 1289-1294